Company Overview and News
IAC/InterActiveCorp (NASDAQ:IAC) stock was trending upward as the company reported its latest quarterly earnings results on Wednesday, which included a profit and revenue beat.
MTCH IAC ANGI
GOLDEN, Colo., Aug. 08, 2018 (GLOBE NEWSWIRE) -- ANGI Homeservices (NASDAQ: ANGI) posted its second quarter financial results on the investor relations section of its website at ir.angihomeservices.com. As announced previously, the company will host a conference call tomorrow, Thursday, August 9, 2018, at 8:30 a.m. Eastern Daylight Time (EDT) to answer questions regarding its second quarter results.
2018-07-18 globenewswire - 1
GOLDEN, Colo., July 18, 2018 (GLOBE NEWSWIRE) -- After the close of market trading on Wednesday, August 8, 2018, ANGI Homeservices (NASDAQ:ANGI) will post its second quarter results on the investor relations section of the company’s website at ir.angihomeservices.com. On Thursday, August 9, 2018 at 8:30 a.m. Eastern Daylight Time (EDT), ANGI Homeservices will host a conference call to answer questions regarding its second quarter results.
The futures traded down again Thursday morning, and it appears that the back and forth trading on Wednesday wore down investors. Once again, the trade and tariff issues were cited as the main reason. Oil jumped again, sparked by a big drop in crude inventories, closing up over 2.5%. With summer vacations in full swing and Americans hitting the road in record numbers to celebrate the fourth of July, you can bet there may be some added pain at the pump.
CBS CBS.A ANGI FLXN RF LMNR CBS.WD ATSG CRM BF.B BF.A BFA TRI CPV MS
2018-05-29 investorplace - 1
Facebook, Inc. (NASDAQ:FB) keeps expanding its reach. The most recent development was the announcement Wednesday of a Facebook home service product. While it might not be a game changer for Facebook stock, it certainly is worth noting.
MTCH FB AMZN GOOGL ANGI PYPL GOOG WMT
2018-05-10 seekingalpha - 1
Good day, and welcome to the IAC and ANGI Homeservices Report First Quarter 2018 Results Conference Call.
2018-05-09 investorplace - 1
IAC/InterActiveCorp (NASDAQ:IAC) reported its latest quarterly earnings results after hours Wednesday, which included data from its successful investments into two major companies.
MTCH FB IAC ANGI
2018-03-28 investorplace - 2
ANGI Homeservices Inc (NASDAQ:ANGI), which was formed when Angie’s List merged with HomeAdvisor, is the leader in the home services industry. The company has ties to several mega-trends that I expect will easily outpace the broader market growth in the years ahead.
IAC/Interactive Corp (NASDAQ:IAC), the Internet content conglomerate put together by onetime broadcast executive Barry Diller, is getting a lot of love from analysts while other, bigger Internet stocks are getting the back of their hand.
MTCH EXPE IAC ANGI TREE
2017-07-27 sec.gov - 6
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to ANGI / Angie's List, Inc. on message board site Silicon Investor.
as of ET